Indianapolis, IN, United States of America

J David Leander

This inventor holds 3 USPTO granted patents. Top assignees: Eli Lilly and Company, Colucid Pharmaceuticals, Inc.. Active years: 1988-2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: J David Leander. Retrieved from https://idiyas.com/inventor/j-david-leander

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 66.7

Average Co-Inventor Count = 1.8

ph-index = 2

Forward Citations = 48(Granted Patents)


Company Filing History:


Years Active: 1988-2012

Loading Chart...
3 patents (USPTO):Explore Patents

Title: J David Leander: Innovator in Pharmacological Compounds

Introduction

J David Leander is a notable inventor based in Indianapolis, IN (US). He holds 3 patents that contribute significantly to the field of pharmacology. His work primarily focuses on compounds that have therapeutic applications, particularly in treating nervous system conditions.

Latest Patents

One of his latest patents involves compounds that inhibit cholinesterase activity. These compounds, upon hydrolysis, release a pharmacologically active agent that can treat various conditions, including cholinergic deficiencies and diseases associated with a deficiency in acetylcholine. Another significant patent is related to methods of preventing emesis and treating sexual dysfunction in mammals using specific tetrahydrobenzindoles. This invention also includes pharmaceutical formulations suitable for these methods.

Career Highlights

Throughout his career, J David Leander has worked with prominent companies such as Eli Lilly and Company and Colucid Pharmaceuticals, Inc. His contributions to these organizations have been instrumental in advancing pharmaceutical research and development.

Collaborations

He has collaborated with notable colleagues, including Nadia M J Rupniak and James F White, enhancing the impact of his research through teamwork and shared expertise.

Conclusion

J David Leander's innovative work in pharmacological compounds showcases his dedication to improving medical treatments. His patents reflect a commitment to addressing critical health issues through scientific advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…